WINSTON SALEM, NC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NOVANT HEALTH INC, founded in 1997, is a large national nonprofit in the Health Care sector that reported $6.5B in total revenue in fiscal year 2024. Revenue surged 63% from the prior year, signaling strong growth momentum. Expenses of $6.2B left a modest 5% surplus.
PART I, LINE 1A: FRINGE OR EXPENSE EXPLANATION FIRST-CLASS OR CHARTER TRAVEL: EXECUTIVES ARE LIMITED TO BUSINESS OR COACH CLASS FOR COMMERCIAL FLIGHTS. HOWEVER, CHARTER TRAVEL IS AVAILABLE FOR CERTAIN EXECUTIVES, BOARD MEMBERS, AND APPROVED BUSINESS PERSONNEL WHO MEET POLICY CRITERIA AND OBTAIN APPROPRIATE APPROVALS. TRAVEL FOR COMPANIONS: COMPANIONS ARE ALLOWED AS PASSENGERS ON CERTAIN CHARTER FLIGHTS PAID BY THE ORGANIZATION. THE VALUE OF THE COMPANION'S FLIGHT IS CALCULATED USING APPLICABLE TAX LAW. THE CALCULATED AMOUNT IS INCLUDED IN THE EXECUTIVE'S TAXABLE COMPENSATION AS PRESCRIBED BY APPLICABLE TAX LAW. DISCRETIONARY SPENDING ACCOUNT: CERTAIN EXECUTIVES RECEIVE A DISCRETIONARY SPENDING ACCOUNT. THE DOLLAR AMOUNT IN THE ACCOUNT IS PRE-APPROVED BY THE COMPENSATION AND LEADERSHIP COMMITTEE OF THE NOVANT HEALTH BOARD OF TRUSTEES. THE EXECUTIVE MAY DEFER THE AMOUNT TO A RETIREMENT ACCOUNT OR THE AMOUNT IS TREATED AS COMPENSATION AND IS SPREAD OUT OVER THE COURSE OF THE YEAR IN THE EXECUTIVE'S PAYCHECKS AS TAXABLE INCOME. HOUSING ALLOWANCE OR RESIDENCE FOR PERSONAL USE: TEMPORARY HOUSING ALLOWANCES ARE INCLUDED IN CERTAIN EXECUTIVE RECRUITMENT AND RELOCATION PACKAGES. THE TAXABLE VALUE OF THESE ARRANGEMENTS IS CALCULATED AND INCLUDED IN THE EXECUTIVE'S TAXABLE COMPENSATION IN ACCORDANCE WITH APPLICABLE FEDERAL LAW AND REGULATIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $6,542,888,138 | $4,015,833,950 | +0.6% |
| Expenses | $6,192,258,960 | $3,902,611,082 | +0.6% |
| Net Income | $350,629,178 | $113,222,868 | +2.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ALVARO DE MOLINA | TRUSTEE | 0.20 |
Director
|
$0 | $0 | $0 |
| BEVERLY MOOSE MD | TRUSTEE | 0.20 |
Director
|
$0 | $0 | $0 |
| BRANDON ADCOCK | TRUSTEE | 0.20 |
Director
|
$0 | $0 | $0 |
| BRIAN ECKEL | TRUSTEE | 0.20 |
Director
|
$725 | $0 | $725 |
| CARL ARMATO | TRUSTEE, PRES/CEO NH | 50.20 |
Officer
Director
|
$6,943,831 | $1,207,106 | $8,150,937 |
| CHARLES HAUSER | TRUSTEE (FR 1/1/24) | 0.20 |
Director
|
$0 | $0 | $0 |
| CHRISTINE KATZIFF | VICE CHAIR | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| CHRISTOPHER DUGGINS MD | TRUSTEE | 0.20 |
Director
|
$0 | $0 | $0 |
| DAVID KING | TRUSTEE | 0.20 |
Director
|
$0 | $0 | $0 |
| DEBORAH ALLY | TRUSTEE (TO 12/31/24) | 0.20 |
Director
|
$725 | $0 | $725 |
| ELWOOD ROBINSON PHD | TRUSTEE | 0.20 |
Director
|
$0 | $0 | $0 |
| IAN MCDONALD | TRUSTEE | 0.20 |
Director
|
$0 | $0 | $0 |
| JAMES AMOS | SECRETARY/TREASURER | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| JASON THOMPSON | TRUSTEE | 0.20 |
Director
|
$0 | $0 | $0 |
| LAURA SCHULTE | CHAIR | 0.50 |
Officer
Director
|
$725 | $0 | $725 |
| ROBERT BARR MD | TRUSTEE (TO 12/31/24) | 0.20 |
Director
|
$0 | $0 | $0 |
| ALICE POPE | EVP/CFO (FR 4/29/24) | 50.00 |
Officer
|
$991,687 | $183,469 | $1,175,156 |
| GEOFFREY GARDNER | CFO (TO 4/28/24) | 50.00 |
Officer
|
$1,254,252 | $45,078 | $1,299,330 |
| DENISE MIHAL | EVP | 50.00 |
Key Emp
|
$1,983,433 | $41,710 | $2,025,143 |
| FRANK EMORY JR | EVP | 50.00 |
Key Emp
|
$1,881,321 | $53,466 | $1,934,787 |
| JAMES DEAN SWINDLE | EVP | 50.00 |
Key Emp
|
$3,290,733 | $41,284 | $3,332,017 |
| JOHN GIZDIC | EVP | 50.00 |
Key Emp
|
$2,208,311 | $269,496 | $2,477,807 |
| KIMBERLY HENDERSON | EVP | 50.00 |
Key Emp
|
$1,421,376 | $199,453 | $1,620,829 |
| ONYEKA NCHEGE | EVP | 50.00 |
Key Emp
|
$1,287,464 | $198,134 | $1,485,598 |
| PAMELA OLIVER MD | EVP | 50.00 |
Key Emp
|
$1,825,710 | $238,642 | $2,064,352 |
| SANJAY GUPTA | EVP | 50.00 |
Key Emp
|
$891,331 | $189,649 | $1,080,980 |
| DAVID DUVALL | FMR SVP MARKETING & COMMUNICATIONS | 45.00 |
Highest
|
$2,118,253 | $0 | $2,118,253 |
| DEREK BERNSTEIN MD | ORTHOPAEDIST | 45.00 |
Highest
|
$2,120,243 | $32,421 | $2,152,664 |
| HOWARD HOMESLEY MD | ORTHOPAEDIST | 45.00 |
Highest
|
$2,983,719 | $57,471 | $3,041,190 |
| JOHN MARCEL MD | ORTHOPAEDIST | 45.00 |
Highest
|
$2,086,151 | $32,409 | $2,118,560 |
| RASHID JANJUA MD | NEUROSURGEON | 45.00 |
Highest
|
$1,981,921 | $57,430 | $2,039,351 |
| ALLISON GREEAR | FMR KE (12/31/21) | 50.00 |
|
$619,144 | $38,215 | $657,359 |
| ANGELA YOCHEM | FMR KE (3/28/23) | 0.00 |
|
$224,358 | $927 | $225,285 |
| CHERE GREGORY MD | FMR KE (12/31/21) | 50.00 |
|
$938,101 | $133,723 | $1,071,824 |
| ERIC ESKIOGLU MD | FMR KE (11/30/22) | 0.00 |
|
$100,800 | $4,222 | $105,022 |
| JESSE CURETON | FMR KE (4/27/23) | 0.00 |
|
$1,039,476 | $25,695 | $1,065,171 |
| JONATHAN APPLEBAUM | FMR KE (12/31/21) | 50.00 |
|
$561,807 | $45,730 | $607,537 |
| KATHRYN LANGFORD | FMR KE (12/31/21) | 50.00 |
|
$635,562 | $15,362 | $650,924 |
| LAURIE WHALIN | FMR KE (12/31/21) | 50.00 |
|
$796,515 | $36,621 | $833,136 |
| SCOTT MYERS | FMR KE (12/31/21) | 50.00 |
|
$961,680 | $40,683 | $1,002,363 |
| SHELBOURN STEVENS | FMR KE (12/31/21) | 0.00 |
|
$605,812 | $24,063 | $629,875 |
| TANYA BLACKMON | FMR KE (3/21/22) | 0.00 |
|
$121,461 | $3,109 | $124,570 |
| THOMAS JENIKE MD | FMR KE (12/31/21) | 50.00 |
|
$897,741 | $141,919 | $1,039,660 |
| WAYNE MORGAN | FMR KE (6/30/21) | 50.00 |
|
$330,242 | $13,134 | $343,376 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $6,542,888,138 | $6,192,258,960 | $14,556,934,673 | $350,629,178 |
| 2023 | $4,015,833,950 | $3,902,611,082 | $9,596,623,033 | $113,222,868 |
| 2022 | $3,193,826,783 | $3,217,545,790 | $8,958,963,272 | $-23,719,007 |
| 2021 | $2,822,105,056 | $2,572,368,985 | $9,335,899,762 | $249,736,071 |
| 2020 | $1,066,591,387 | $1,042,047,954 | $5,365,829,428 | $24,543,433 |
| 2019 | $1,019,396,293 | $963,052,061 | $4,524,203,756 | $56,344,232 |
| 2018 | $911,864,857 | $825,152,601 | $3,940,829,650 | $86,712,256 |
Compare NOVANT HEALTH INC with other nonprofits in North Carolina and across the country.